GlobeNewswire Inc.··NaPrecipio Faces Q1 Headwinds as Revenue Stalls, EBITDA Swings Negative
Precipio ($PRPO) reports flat Q1 revenue of $6.71M and negative EBITDA of $(0.16)M, citing temporary headwinds from delayed shipments and CMS cuts; expects recovery in H2 2026.
PRPOcancer diagnosticsAdjusted EBITDA